Bachem Holding places shares of approx. CHF 584 m. The advisors

Bachem Holding, an innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides, has raised CHF 583.5 million through an accelerated bookbuilding process by issuing 750,000 new shares at a placement price of CHF 778 per share.  Mor­gan Stan­ley and UBS were act­ing as Joint Glob­al Coordin­at­ors and Joint Book­run­ners and Zürch­er Kan­ton­al­bank as Joint Book­run­ner in the offering.

The capital increase serves as investment financing in the capacity expansion of Bachem.

The advisors

Vischer is advising Bachem Holding on this capital increase with a team consisting of partner Matthias Staehelin (pictured), senior associate Sebastian Flückiger and  Lukas Wendt (all corporate/m&a) as well as partner Nadia Tarolli (taxes).

Advestra  acted as leg­al coun­sel to the syn­dic­ate banks. The team included Annette Weber (pictured) Thomas Reut­ter and Valérie Bayard (all cap­it­al markets).